Lifestyle
- Regular physical activity
- Stress management
- Adequate sleep
Serum Transferrin · Siderophilin
Transferrin quantifies the level of iron-binding glycoprotein in the blood, reflecting iron transport capacity.
Ranges may vary slightly based on laboratory standards.
Transferrin is a glycoprotein primarily responsible for the transportation of iron throughout the bloodstream to various tissues. It binds iron ions and delivers them to cells via transferrin receptors, playing a crucial role in iron homeostasis. Researchers have observed that transferrin levels can provide insights into the body's iron status and are often evaluated alongside other markers such as ferritin and transferrin saturation. Clinically, transferrin levels are significant in diagnosing and managing conditions related to iron metabolism, including iron deficiency anemia and anemia of chronic disease. Elevated transferrin levels may indicate iron deficiency, as the body increases transferrin production to maximize iron transport. Conversely, low transferrin levels can be associated with conditions like chronic inflammation or liver disease. For athletes and biohackers, maintaining optimal transferrin levels is crucial for ensuring efficient oxygen transport and energy metabolism, which can impact performance and recovery. However, researchers have found that factors such as diet, inflammation, and liver function can confound transferrin measurements. Fasting is not required for testing, but it is recommended to consider potential interfering factors such as recent iron supplementation or acute illness.
Klinische Bedeutung
Elevated transferrin levels often indicate iron deficiency, as the body increases transferrin production to enhance iron transport. Reduced transferrin levels may suggest chronic inflammation, liver disease, or malnutrition.
Progressively rising transferrin levels suggest worsening iron deficiency. Re-test in 4 weeks if outside optimal range.
Falling transferrin levels may indicate improving iron status or the onset of chronic disease.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a physician before starting iron supplementation, especially if underlying conditions are suspected.
Transferrin levels can vary throughout the day; consistent timing for tests is recommended.
Testing Frequency
Annually for healthy adults; more frequently if managing iron-related conditions.
Correlated with
Current research suggests that the reference ranges for transferrin and its receptor, particularly in diverse populations and clinical contexts, remain debated, with optimal targets for diagnosis and management of iron deficiency anemia still not established. Emerging research directions include the exploration of transferrin receptor ratios in differentiating types of anemia and the role of transferrin in ferroptosis. Unanswered clinical questions include the impact of physiological factors on transferrin levels and the effectiveness of novel biomarkers in routine diagnostics.
1,892
Total Citations
14
Human/RCT
4.2
Avg. Influence
2024
Latest
This study identified the transferrin receptor as a specific marker for ferroptosis, a regulated cell death process. Researchers developed a monoclonal antibody that effectively detects cells undergoing ferroptosis by targeting the human transferrin receptor 1 protein. This finding may enhance the understanding of ferroptosis in various biological contexts.
This study explored laboratory markers for alcohol abuse, highlighting serum carbohydrate-deficient transferrin (CDT) as a promising marker. Researchers found that CDT has greater potential than existing tests for detecting alcohol abuse, especially when used in combination with other markers.
This study focused on transferrin-binding proteins from Neisseria meningitidis and their ability to elicit protective antibodies in mice. Researchers found that immunization with these proteins significantly increased survival rates against bacterial challenges.
Researchers examined transferrin saturation (TSAT) as a biomarker for body iron status. They found that TSAT is important for detecting iron deficiency and overload, but caution is needed during interpretation, especially in inflammatory conditions. The study also linked TSAT levels to cardiovascular mortality, suggesting potential for risk assessment.
Researchers discussed the challenges in diagnosing congenital disorders of glycosylation (CDG) and noted that serum transferrin isoelectrofocusing is only positive in about 60% of cases. They provided practical tools to aid in CDG diagnosis, emphasizing the importance of recognizing clinical features suggestive of these disorders.
Researchers observed that serum transferrin receptor levels are a useful indicator of iron deficiency and erythropoiesis. They highlighted its clinical utility in distinguishing between different types of anemia, particularly in identifying iron deficiency anemia. The study supports the routine use of this marker in evaluating anemic patients.
This review examined various established and novel biomarkers for diagnosing iron deficiency, including transferrin and ferritin. Researchers found that understanding these markers can improve patient care and guide future research in iron metabolism. The review highlights the complexities and controversies surrounding the diagnostic criteria for different types of anemia.
This pilot study evaluated the effects of oral D-galactose supplementation in patients with phosphoglucomutase-1 deficiency. Researchers found significant improvements in transferrin glycosylation and other biomarkers, suggesting its potential benefits.
This study focused on the clinical significance of transferrin receptors in iron metabolism. Researchers found that measuring serum transferrin receptor levels can differentiate between iron deficiency anemia and other types of anemia. They highlighted the importance of transferrin receptor-ferritin ratios in assessing iron status.
Researchers summarized efforts to standardize the measurement of carbohydrate-deficient transferrin (CDT), an alcohol biomarker. They highlighted the establishment of reference laboratories and procedures to improve the consistency of CDT test results.
8
Total Trials
1,576
Total Enrolled
Medical University of Vienna
800
2026
The primary outcome of the study is 30-day all-cause mortality in ICU patients.
John M. Buatti
15
2025
Relationship between T2 (observed)-weighted imaging (T2*) magnetic resonance imaging relation time and dimeric transferrin receptor expression
Institut National de la Santé Et de la Recherche Médicale, France
20
2022
Search for the maximal tolerated and effective dose of oral artesunate to regulate iron homeostasis and Transferrin 1 receptor (TfR1) immunofluorescence in Peripheral Blood Mononuclear Cells (PBMCs)
Rennes University Hospital
239
2021
The primary evaluation criteria is the Physical Component Score of the SF-36 questionnaire at the end of the study period (two years)
Rennes University Hospital
260
2017
Quality of life questionnaire SF 36
London School of Hygiene and Tropical Medicine
206
2016
transferrin saturation (TSAT)
University of Zurich
31
2015
Beta-2-Transferrin positive or negative
Prothya Biosolutions
5
2010
Hemoglobin
Research publications about Transferrin over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer